Abstract:The effects of vitamin supplements and/or diet on the levels of vitamin C, vitamin B6, and vitamin B12 in milk and blood of lactating women were determined. At the end of gestation, subjects were divided into two lactation groups: supplemented (10 subjects) and nonsupplemented (seven subjects). Milk samples were collected from 5 to 7 days and 43 to 45 days postpartum. Fasting blood samples were drawn at 8 and 46 days postpartum for vitamin C, B6, and B12 status measurements. Dietary records of all foods consum… Show more
“…The mean concentration of ascorbic acid in maternal milk (Table 3) was similar to that reported in other studies (Fomon, 1974;Thomas et al 1979;Sneed et al 1981;Byerley & Kirksey, 1985;Schwartz, 1985). However, it was greater than that recorded in still others (Bates et al 1983(Bates et al , 1994Committee on Nutrition, 1985) (Table 4).…”
Section: Discussionsupporting
confidence: 88%
“…Others have reported that when intake is low, breast milk ascorbic acid levels are sensitive to supplementation. However, when intake is high, breast milk levels are much less sensitive (Thomas et al 1979;Sneed et al 1981).…”
The aim of the present investigation was to study the relationship between ascorbic acid status during the third trimester of pregnancy and levels of this vitamin in transition milk (days 13-14 of lactation) and mature milk (day 40 of lactation). To this end, the pregnancies and lactation periods of fifty-seven healthy women between 18 and 35 years of age (27 (SD 3.7) years) were monitored. Vitamin intake during the third trimester was determined by recording the consumption of foods over 5d, and by registering the quantities provided by dietary supplements. Ascorbic acid levels in maternal serum during this stage of pregnancy, and in transition and mature milk samples, were determined by spectrophotometry. Those subjects with ascorbic acid intakes below that recommended (80 mg/d) (group L) showed lower consumption of fruit and vegetables than did those with greater intakes (group H). The consumption of ascorbic acid supplements was very low, and was only seen in three group H subjects. The difference in ascorbic acid intake was reflected at serum level. Group L subjects showed significantly lower serum values than did group H subjects (30.1 (SD 36.3) pmol/l compared with 101
“…The mean concentration of ascorbic acid in maternal milk (Table 3) was similar to that reported in other studies (Fomon, 1974;Thomas et al 1979;Sneed et al 1981;Byerley & Kirksey, 1985;Schwartz, 1985). However, it was greater than that recorded in still others (Bates et al 1983(Bates et al , 1994Committee on Nutrition, 1985) (Table 4).…”
Section: Discussionsupporting
confidence: 88%
“…Others have reported that when intake is low, breast milk ascorbic acid levels are sensitive to supplementation. However, when intake is high, breast milk levels are much less sensitive (Thomas et al 1979;Sneed et al 1981).…”
The aim of the present investigation was to study the relationship between ascorbic acid status during the third trimester of pregnancy and levels of this vitamin in transition milk (days 13-14 of lactation) and mature milk (day 40 of lactation). To this end, the pregnancies and lactation periods of fifty-seven healthy women between 18 and 35 years of age (27 (SD 3.7) years) were monitored. Vitamin intake during the third trimester was determined by recording the consumption of foods over 5d, and by registering the quantities provided by dietary supplements. Ascorbic acid levels in maternal serum during this stage of pregnancy, and in transition and mature milk samples, were determined by spectrophotometry. Those subjects with ascorbic acid intakes below that recommended (80 mg/d) (group L) showed lower consumption of fruit and vegetables than did those with greater intakes (group H). The consumption of ascorbic acid supplements was very low, and was only seen in three group H subjects. The difference in ascorbic acid intake was reflected at serum level. Group L subjects showed significantly lower serum values than did group H subjects (30.1 (SD 36.3) pmol/l compared with 101
“…When comparing infants from multivitamin-supplemented mothers to infants from non-multivitamin-supplemented mothers, we found a major effect in serum vitamin B12 at 6 weeks that was sustained through 6 months of age. Observational studies had suggested that the vitamin B12 status of newborns is strongly associated with that of their mothers (Bjorke Monsen et al, 2001) and that correction of deficiencies through vitamin B12 supplementation among presumably HIV-uninfected mothers resulted in greater B12 concentrations in breast milk (Thomas et al, 1979(Thomas et al, , 1980Sneed et al, 1981). It has been described that vitamin B12 concentrations decrease in the newborn during the first 6-8 weeks (Bjorke Monsen & Ueland, 2003); our results suggest that maternal supplementation with multivitamins at multiples of the recommended dietary allowance (RDA) in USA could prevent such a decrease.…”
Section: Discussionmentioning
confidence: 99%
“…Studies among presumably HIV-uninfected women have shown that supplementation with vitamins A and B12 during early lactation increases the concentrations of nutrients in breast milk and results in improved vitamin status of infants during the first 6 months (Thomas et al, 1979;Sneed et al, 1981;Stoltzfus et al, 1993;Roy et al, 1997;Muslimatun et al, 2001;Bahl et al, 2002). Therefore, it has been proposed that vitamin supplementation to lactating mothers may be an efficient way to improve the vitamin status of both mothers and infants (Stoltzfus et al, 1993).…”
Objective: We examined whether supplementation with vitamin A and/or vitamins B, C, and E to HIV-infected women during pregnancy and lactation is related to increased concentrations of vitamins A, B12, and E in their infants during the first 6 months of life. Design: We carried out a randomized clinical trial among 716 mother-infant pairs in Dar-es-Salaam, Tanzania. Women were randomly allocated to receive a daily oral dose of one of four regimens: vitamin A, multivitamins (B, C, and E), multivitamins including A, or placebo. Supplementation started at first prenatal visit and continued after delivery throughout the breastfeeding period. The serum concentration of vitamins A, E and B12 was measured in infants at 6 weeks and 6 months postpartum. Results: Maternal vitamin A supplementation increased serum retinol in the infants at 6 weeks (mean difference ¼ 0.09 mmol/l, Po0.0001) and 6 months (mean difference ¼ 0.06 mmol/l, P ¼ 0.0002), and decreased the prevalence of vitamin A deficiency, but had no impact on serum vitamins E or B12. Multivitamins increased serum vitamin B12 at 6 weeks and 6 months (mean differences ¼ 176 pmol/l, Po0.0001 and 127 pmol/l, Po0.0001, respectively) and vitamin E (mean differences ¼ 1.8 mmol/l, P ¼ 0.0008 and 1.1 mmol/l, P ¼ 0.004, respectively) and decreased the prevalence of vitamin B12 deficiency. Conclusions: Vitamin supplementation to HIV-1-infected women is effective in improving the vitamin status of infants during the first 6 months of age.
“…() 16 9 7 USA Mean ± SE (a) Supplementation with vitamin B6 (b) Total vitamin B6 intake Supplemented group 5–7 days post‐partum (a) 4 (b) 5.33 ± 0.29 (SE) 43–45 days post‐partum (a) 4 (b) 5.12 ± 0.31 (SE) Unsupplemented group 5–7 days post‐partum (a) 0 (b) 1.52 ± 0.40 (SE) 43–45 days post‐partum (a) 0 (b) 1.41 ± 0.56 (SE) – 5–7 days post‐partum 43–45 days post‐partum 5–7 days post‐partum 43–45 days post‐partum Vitamin B6 Mean ± SD 248 ± 60 240 ± 57 123 ± 34 120 ± 33 Microbiological assay ( Saccharomyces uvarum ) 4‐day dietary records (from 4 to 7 days post‐partum and 42 to 45 days post‐partum) Multivitamin and mineral supplementation compared with no supplementation Expressed milk before taking supplementation or placebo No information on whether the infants were born at term or not Plasma PLP not assessed Styslinger and Kirksey () 24 6 6 6 6 USA Mean ± SEM: (a) Supplemental intake: four doses of PN‐HCl (b) Dietary vitamin B6 intake (c) Total vitamin B6 intake (a) 0 (b) 2.0 ± 0.1 (c) 2.0 ± 0.1 (a) 2.5 (b) 1.9 ± 0.1 (c) 4.4 ± 0.1 (a) 10.0 (b) 1.6 ± 0.1 (c) 11.3 ± 0.2 (a) 20.0 (b) 1.7 ± 0.5 (c) 21.1 ± 0.4 –2–3 months post‐partum (mean stage of lactation: 11 weeks post‐partum)Vitamin B6 (Mean ± SEM) 93 ± 8 192 ± 16 247 ± 25 413 ± 45 Microbiological assay ( Saccharomyces uvarum ) Maternal intake estimated by a three‐day dietary record for 18 women, and a two‐day dietary record for three women Dietary records not available for three women Multivitamin and multimineral supplementation Supplementation was taken for three consecutive days Full‐term infants Plasma PLP concentration not assessed Thomas et al. () 17 10 7 USA Mean ± SE (a) Supplementation with vitamin B6 (b) Total vitamin B6 intake Supplemented group 5–7 days post‐partum (a) 4.0 (b) 5.69 ± 0.65 (SE) 43–45 days post‐partum (a) 4.0 (b) 5.11 ± 0.35 (SE) Unsupplemented group 5–7 days post‐partum (a) 0 (b) 1.45 ± 0.62 (SE) 43–45 days post‐partum (a) 0 (b) 0.84 ± 0.22 (SE) – 5–7 days post‐partum 43–45 days post‐partum 5–7 days post‐partum 43–45 days post‐partum Vitamin B6 Mean ± SE 225 ± 87 237 ± 57 128 ± 59 204 ± 53 Microbiological assay ( Saccharomyces uvarum ) Four‐day dietary records (from 4 to 7 days post partum and 42 to 45 days post partum) Multivitamin and multimineral supplementation Milk collection: 3‐day periods at I and 6 weeks post partum Expressed milk before taking supplementation For the unsupplemented group, expressed milk bef...…”
Section: Appendix a – Concentrations Of Vitamin B6 In Breast Milk Of mentioning
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) derives Dietary Reference Values (DRVs) for vitamin B6. The Panel considers that plasma pyridoxal 5 0 -phosphate (PLP) concentration is the biomarker of status suitable for deriving DRVs for vitamin B6. Considering that a plasma PLP concentration of 30 nmol/L, as a population mean, is indicative of an adequate vitamin B6 status, the Panel proposes to use this cut-off value to set Average Requirements (ARs). Population Reference Intakes (PRIs) are derived for adults and children from ARs, assuming a coefficient of variation (CV) of 10%. For women, the AR and PRI are set at 1.3 and 1.6 mg/day. For men, the AR of 1.5 mg/day is derived by an allometric scaling from the AR for women, and a PRI of 1.7 mg/day is set. For all infants aged 7-11 months, an Adequate Intake of 0.3 mg/day is set, averaging the results of two extrapolation approaches based on an allometric scaling: upwards extrapolation from the estimated vitamin B6 intake of exclusively breastfed infants from birth to 6 months, and downwards extrapolation from the ARs for adults applying a growth factor. For all children, ARs are derived from adult ARs using an allometric scaling and growth factors. For children of both sexes aged 1-14 years, ARs range between 0.5 and 1.2 mg/day. For children aged 15-17 years, the Panel derives the same ARs as for adults. PRIs for children aged 1-17 years range between 0.6 and 1.7 mg/day. Extrapolation of ARs by an allometric scaling considered differences in reference body weight. For pregnant and lactating women, additional requirements are considered, based on the uptake of vitamin B6 by the fetal and maternal tissues and the losses through breast milk, and PRIs of 1.8 and 1.7 mg/day, respectively, are derived.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.